J&J, Roche, AstraZeneca Poised to Have Highest Orphan Drug Sales by End of Decade
Seeking Alpha13:00 ET
Amgen's Blincyto Data Send Cullinan Higher
Seeking AlphaApr 27 15:39 ET
AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts
Yahoo FinanceApr 27 03:16 ET
Express News | BMO Capital Maintains Outperform on AstraZeneca, Raises Price Target to $82
BenzingaApr 26 14:02 ET
AstraZeneca Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/26/2024 8.85% BMO Capital $80 → $82 Maintains Outperform 04/16/2024 — Deutsche Bank Upgrades Sell → Ho
BenzingaApr 26 14:02 ET
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Yahoo FinanceApr 26 11:34 ET
Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Yahoo FinanceApr 26 09:23 ET
Top 4 Health Care Stocks That May Plunge This Month
As of April 26, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicato
BenzingaApr 26 08:09 ET
Barclays Raises AstraZeneca PT, Affirms at Overweight
Barclays on Friday raised the price target of British pharmaceutical company AstraZeneca (AZN.L, AZN.ST) to 135.00 pounds sterling from 130.00 pounds, while reiterating its overweight rating. Price (G
MT NewswiresApr 26 07:41 ET
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN) and BioMarin Pharmaceutical (BMRN)
TipRanksApr 26 07:20 ET
Express News | AstraZeneca : BMO Raises Target Price to $82 From $80
ReutersApr 26 07:02 ET
Top Gap Ups and Downs on Thursday: META, AZN, CAT and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
moomoo NewsApr 25 20:13 ET
Health Care Drops Amid Mixed Earnings -- Health Care Roundup
Health-care companies fell after mixed earnings. Bristol-Myers Squibb shares tumbled after the drug giant said it would lay off roughly 2,200 people in an effort to compensate for a slowdown in the s
Dow JonesApr 25 17:15 ET
Fusion Pharmaceuticals: AstraZeneca to Acquire All of Fusion's Shrs at $21 Each in Cash >FUSN
Fusion Pharmaceuticals: AstraZeneca to Acquire All of Fusion's Shrs at $21 Each in Cash >FUSN
Dow JonesApr 25 16:38 ET
Fusion Pharmaceuticals: Ontario Superior Court of Justice Issues Interim Order Regarding AstraZeneca Deal >FUSN
Fusion Pharmaceuticals: Ontario Superior Court of Justice Issues Interim Order Regarding AstraZeneca Deal >FUSN
Dow JonesApr 25 16:37 ET
Press Release: Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order
Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order PR Newswire HAMILTON, ON and BOSTON, April 25, 2024 HAMILTON, ON and BOSTON, April 2
Dow JonesApr 25 16:34 ET
Sector Update: Health Care Stocks Decline Late Afternoon
Health care stocks retreated late Thursday afternoon, with the NYSE Health Care Index down 0.4% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.6%. The iShares Biotechnology ETF (IBB) dro
MT NewswiresApr 25 15:48 ET
AstraZeneca -5%, Anglo American, Deutsche Bank +8%: European Stocks in Focus
By Chelsey Dulaney and Katy Barnato A slate of strong earnings from U.K.-listed companies helped drive the FTSE 100 to another record close. In mainland Europe, Deutsche Bank closed at more-than six
WSJApr 25 14:48 ET
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
BenzingaApr 25 13:57 ET
Earnings Call Summary | AstraZeneca(AZN.US) Q1 2024 Earnings Conference
The following is a summary of the AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript:Financial Performance:AstraZeneca reported a revenue growth of 19% in Q1 2024, driven by significant product sa
moomoo AIApr 25 13:48 ET · Conference Call
No Data
No Data